BUCCELLATI, CAROLA
BUCCELLATI, CAROLA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Rapid Metabolization of Protectin D1 by β-Oxidation of Its Polar Head Chain
2019 L. Balas, P. Risé, D. Gandrath, G. Rovati, C. Bolego, F. Stellari, A. Trenti, C. Buccellati, T. Durand, A. Sala
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain
2019 J.S. Kramer, S. Woltersdorf, T. Duflot, K. Hiesinger, F.F. Lillich, F. Knöll, S.K. Wittmann, F. Klingler, S. Brunst, A. Chaikuad, C. Morisseau, B.D. Hammock, C. Buccellati, A. Sala, G. Rovati, M. Leuillier, S. Fraineau, J. Rondeaux, V. Hernandez-Olmos, J. Heering, D. Merk, D. Pogoryelov, D. Steinhilber, S. Knapp, J. Bellien, E. Proschak
Arachidonic acid and docosahexaenoic acid metabolites in the airways of adults with cystic fibrosis: Effect of docosahexaenoic acid supplementation
2019 E. Teopompi, P. Rise, R. Pisi, C. Buccellati, M. Aiello, G. Pisi, C. Tripodi, V. Fainardi, E. Clini, A. Chetta, G. Rovati, A. Sala
CHF6001 Inhibits NF-κB activation and neutrophilic recruitment in LPS-induced lung inflammation in mice
2019 F.F. Stellari, A. Sala, F. Ruscitti, C. Buccellati, A. Allen, P. Risé, M. Civelli, G. Villetti
Increased dietary levels of α-linoleic acid inhibit mammary tumor growth and metastasis
2017 M. Vara Messler, M.E. Pasqualini, A. Comba, R. Silva, C. Buccellati, A. Trenti, L. Trevisi, A.R. Eynard, A. Sala, C. Bolego, M.A. Valentich
Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk
2017 S. Carnevali, C. Buccellati, B. Chiara, B. Massimo, G. Rovati, A. Sala
In vitro pharmacological evaluation of multitarget agents for thromboxane prostanoid receptor antagonism and COX-2 inhibition
2016 M. Hoxha, C. Buccellati, V. Capra, D. Garella, C. Cena, B. Rolando, R. Fruttero, S. Carnevali, A. Sala, G.E. Rovati, M. Bertinaria
Antiinflammatory and antioxidant effects of H2O2 generated by natural sources in Il1β-treated human endothelial cells
2015 A. Toniolo, C. Buccellati, A. Trenti, L. Trevisi, S. Carnevali, A. Sala, C. Bolego
Transcellular biosynthesis of eicosanoid lipid mediators
2015 V. Capra, G.E. Rovati, P. Mangano, C. Buccellati, R.C. Murphy, A. Sala
A potential role of PUFAs and COXIBs in cancer chemoprevention
2015 M. Vara Messler, C. Buccellati, L. Pustina, G. Folco, G..E. Rovati, M. Hoxha
Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: signaling through the CysLT2 receptor
2015 V. Capra, C. Carnini, M.R. Accomazzo, A. Di Gennaro, M. Fiumicelli, E. Borroni, I. Brivio, C. Buccellati, P. Mangano, S. Carnevali, G. Rovati, A. Sala
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration
2015 N. Moretto, P. Caruso, R. Bosco, G. Marchini, F. Pastore, E. Armani, G. Amari, A. Rizzi, E. Ghidini, R. De Fanti, C. Capaldi, L. Carzaniga, E. Hirsch, C. Buccellati, A. Sala, C. Carnini, R. Patacchini, M. Delcanale, M. Civelli, G. Villetti, F. Facchinetti
A New Gateway for Rheumatoid Arthritis: COXIBs with an Improved Cardiovascular Profile
2014 M. Hoxha, V. Capra, C. Buccellati, A. Sala, C. Cena, R. Fruttero, M. Bertinaria, G.E. Rovati
Principi di farmacologia : classificazione, interazioni, indicazioni cliniche
2014 C. Buccellati, V. Capra, A. Sala, P. Risé
Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress
2013 A. Toniolo, C. Buccellati, C. Pinna, R.M. Gaion, A. Sala, C. Bolego
Droghe e farmaci psicoattivi
2012 C. Buccellati, A. Sala
Effect of essential fatty acids on cell survival in an in-vitro model of breast cancer
2012 M. Vara-Messler, A. Comba, C. Buccellati, A. Sala, M.A. Valentich, M.E. Pasqualini
Bronchodilators Modulate Inflammation In Chronic Obstructive Pulmonary Disease Subjects
2012 P. Santus, C. Buccellati, S. Centanni, F. Fumagalli, P. Busatto, F. Blasi, A. Sala
The pulmonary pharmacology of [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1, 3-benzenedicarboxamide](2NTX-99), an anti-atherotrombotic compound with therapeutic potential in pathological conditions that target lung vasculature
2012 I. Brivio, C. Buccellati, F. Fumagalli, J. Hodge, C. Casagrande, G. Folco, A. Sala
Designing Multitarget Anti-inflammatory Agents: Chemical Modulation of the Lumiracoxib Structure toward Dual Thromboxane Antagonists-COX-2 Inhibitors
2012 M. Bertinaria, M.A.A.G Shaikh, C. Buccellati, C. Cena, B. Rolando, L Lazzarato, R. Fruttero, A. Gasco, M. Hoxha, V. Capra, A. Sala, G.E. Rovati